Hamartoma Syndrome, Multiple D006223

Related MeSH Hierarchy (4)

Diseases [C] » Neoplasms [C04] » Hamartoma » Hamartoma Syndrome, Multiple

Diseases [C] » Neoplasms [C04] » Neoplasms, Multiple Primary » Hamartoma Syndrome, Multiple

Diseases [C] » Neoplasms [C04] » Neoplastic Syndromes, Hereditary » Hamartoma Syndrome, Multiple

Description

A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.   MeSH

Hierarchy View

Subtype Terms (1)

Proteus Syndrome
4 drugs (1 approved, 3 experimental)


Phase 2 Indicated Drugs (2)

Phase 1 Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.